NCT06679634 2026-04-14
Retinoblastoma Phase II Expanded Access Clinical Trial
Targeted Therapy Technologies, LLC
Phase 2 Recruiting
Clinical Trials
10 trialsNCT05504291 2026-02-17
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Children's Oncology Group
Phase 2 Recruiting
NCT05650749 2025-12-29
GPC2
Children's Hospital of Philadelphia
Phase 1 Recruiting
NCT04681417 2025-11-28
RETINO 2018
Institut Curie
Phase 2/3 Recruiting
NCT04040205 2025-07-20
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Medical College of Wisconsin
Phase 2 Recruiting
NCT06424301 2025-06-26
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1 Recruiting
NCT06972602 2025-05-15
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1 Recruiting
NCT04903678 2025-02-25
Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma
Eye & ENT Hospital of Fudan University
Phase NA Recruiting
NCT05080010 2021-10-15
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Sun Yat-sen University
Phase 3 Recruiting
NCT04799002 2021-03-16
Topotecan and Melphalan for Retinoblastoma
Sun Yat-sen University
Phase 3 Recruiting